A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.
about
Bmi1 regulates auditory hair cell survival by maintaining redox balance.Early investigational drugs for hearing loss.Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis.Anti-photoaging properties of the phosphodiesterase 3 inhibitor cilostazol in ultraviolet B-irradiated hairless miceGinkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial.Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis.The Potential Use of Melatonin for Preventing Cisplatin Ototoxicity: An Insight for a Clinical Approach
P2860
Q30396588-BAD45B3D-059C-4981-9EE2-26A14A7CFAABQ33847686-7570F3F2-A736-410F-8A58-7B0506D2E5BBQ36110782-4CEEF0DA-0596-456E-9DFB-A33C8F0AF302Q37147840-0433AAFA-CF24-45F7-9190-61129EFCCFB7Q38902427-3C14DD31-8EFF-426C-855E-CA8128F688FFQ41130951-D202BF79-30A9-4067-9E97-6CF3C35F37A7Q46731720-2EFAFD2F-E6F3-4EBD-9D65-B8EB64770F07Q59048801-7B4B3CB1-C385-4445-994B-825B75FDC360
P2860
A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@en
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@nl
type
label
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@en
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@nl
prefLabel
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@en
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@nl
P2093
P2860
P921
P356
P1476
A combination of cilostazol an ...... al apoptotic and ERK pathways.
@en
P2093
P2860
P2888
P356
10.1038/CDDIS.2013.33
P577
2013-02-21T00:00:00Z
P5875
P6179
1008950448